◆ 会议时间：2024年3月13日至15日
◆ 会议地点：瑞典 斯德哥尔摩
◆ 会议简介：
2024年欧洲生殖器官感染和肿瘤研究组织(EUROGIN)大会-国际多学科HPV大会将于2024年3月13日至15日在瑞典斯德哥尔摩举行。EUROGIN大会将提供一个和主题相关的高质量、创新的科学计划，介绍有关各种HPV相关疾病的最新科学信息，会议的一个主要优势是将聚集来自学术界、专业组织和患者组织的杰出国际代表。多年来EUROGIN大会作为HPV感染和相关癌症领域领先的国际会议之一而赢得了极高的声誉，为多学科的高水平科学交流宣提供了一个平台，宗旨是将科学发现转化为临床实践。欧洲生殖器官感染和瘤变研究组织(EUROGIN)汇集了从事生殖感染和肿瘤研究的临床医生和科学家。未经本站许可禁止复制转载摘录本站任何内容-领域国际医学会议网(lingyuint.com)。
EUROGIN 2024 - EUropean Research Organisation on Genital Infection and Neoplasia Congress
International Multidisciplinary HPV Congress
Date: March 13-15, 2024
Venue: Stockholm, Sweden
摘要征文投稿：
Abstract Submission Deadline October 15, 2023
The final decision of the Scientific Committee will be announced before December 2023;
点此提交摘要>>>Submit Abstract>>>
- Abstracts must be submitted through the online submission system;
- Maximum length (body of abstract): 2700 characters (spaces included);
- The title should be written in UPPER CASE (capitals); (keep it as short as possible, clearly indicating the nature of the investigation;
- Please avoid complex mathematical formulae; the system allows to insert simple tables;
- Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned;
- All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract;
- Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered;
- Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles;
- Only standard abbreviations may be used without definition. Data must be given in units widely used in literature;
- Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them;
- Drugs must be identified by their generic names and no company names should be mentioned in the title of the abstract.
For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form.
- HPV disease and COVID-19
- Viral and molecular biology
- Epidemiology and natural history
- Pathogenesis
- Immunology
- HPV prophylactic vaccines
- HPV therapeutic vaccines
- Immunotherapy - Immuno-oncology - New treatments
- HPV testing
- HPV screening
- Screening for women difficult to reach
- Triage of HPV positive women
- Self-sampling
- Genotyping
- Molecular markers
- Screening methods
- Methylation
- Microbiome
- Serology
- New technologies
- Artificial intelligence - Big data - Machine learning
- Diagnostic procedures / management
- Risk management
- Colposcopy
- Cervical neoplasia
- Vulvar and vaginal diseases and neoplasia
- Anal neoplasia
- Oral HPV infection
- HPV and oropharynx / Head and neck cancer
- HPV and associated skin diseases
- Genital warts
- HPV transmission
- Sexually transmitted diseases and HIV infection
- Conventional therapies
- Economics and modelling
- Advocacy, acceptability and psychology
- Health education
- Low resource settings
- Public health
- Fertility and HPV
注册费：
Super Early Bird October 3, 2022
Early Bird February 12, 2023
Regular Rate From February 13, 2023
Conference Pass 4-days (Mar. 13-16)：
Standard ：€690
Instead of €960
Delegates from Nordic Countries*： €590
Instead of €800
Students - Middle Income Countries** €480
Instead of €670
Low Income Countries*** €400
Instead of €590
Conference Pass includes:
- Eurogin Sessions
- Colposcopy Course
- Commercial Exhibition
- Program Book
- Congress Bag
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
